Khalili Gheidariy et al., 2020 - Google Patents
Evaluation and optimization of chick embryo fibroblasts for production of a fowl pox vaccine based on cell cultureKhalili Gheidariy et al., 2020
View PDF- Document ID
- 17642493456758849921
- Author
- Khalili Gheidariy M
- Ghaderi M
- Taghizadeh M
- Shahkarami M
- Karimi Razakani H
- et al.
- Publication year
- Publication venue
- مجله ویروس شناسی ایران
External Links
Snippet
Abstract Background and Aims: For more than half a century, the production of fowl pox vaccine at Razi Vaccine and Serum Research Institute, has been carried out by injection method in the chick chorioallantoic membrane (CAM) and the vaccine has a favorable and …
- 229960005486 vaccines 0 title abstract description 106
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviradae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miller et al. | Newcastle disease | |
| McFerran et al. | Some properties of an avirulent Newcastle disease virus | |
| Awad et al. | Immune responses and interactions following simultaneous application of live Newcastle disease, infectious bronchitis and avian metapneumovirus vaccines in specific-pathogen-free chicks | |
| CN109439634A (en) | Pseudorabies virus genetic engineering attenuated vaccine strain and its application | |
| KR101099629B1 (en) | New Newcastle Disease Virus Ｋ148 / 08, and Newcastle Disease Vaccine Containing the Virus | |
| US20220202931A1 (en) | Attenuated ibv with extended cell culture and tissue tropism | |
| Capua et al. | A ‘novel’infectious bronchitis strain infecting broiler chickens in Italy | |
| Lucio et al. | Response of susceptible versus immune chicks to killed, live-modified, and wild infectious bursal disease virus vaccines | |
| Siddique et al. | Determination of host specificity of pigeon pox and fowl pox viruses isolated from a field outbreak | |
| Khalili Gheidariy et al. | Evaluation and optimization of chick embryo fibroblasts for production of a fowl pox vaccine based on cell culture | |
| Perelman et al. | Use of controlled exposure as a novel method for reovirus arthritis/tenosynovitis prevention. A preliminary report | |
| US6451321B1 (en) | IBDV strain in ovo administration | |
| JP2023542923A (en) | Attenuated isolate of infectious bronchitis virus strain DMV1639 | |
| RU2542440C2 (en) | Live vaccine for avian diseases | |
| Khehra et al. | In vitro and in vivo studies on the pathogenicity of avian pneumovirus for the chicken oviduct | |
| WO2014061914A1 (en) | Infectious bronchitis virus k40/09 strain, and vaccine for infectious bronchitis using same | |
| De Boer et al. | On epizootiology and control of lymphoid leukosis in chickens | |
| Meher et al. | Detection of MDA titer of ınfectious bronchitis virus and comparison of antibody titer produced by two different ınfectious bronchitis vaccine | |
| Ebrahimi et al. | Evaluation of efficacy of Razi fowl pox vaccine in comparison with the commercial fowl pox vaccine in SPF chickens by challenge Test | |
| TWI300807B (en) | Attenuated avian infectious bronchitis virus vaccines | |
| Mohammadi et al. | Combination of H120 and 793/B types of infectious bronchitis virus vaccine protects chickens against challenge with OX like strain of the virus | |
| Alazawy | Serological study by using the ELISA technique to identification of avian infectious bronchitis disease among some fields of broiler chickens in Diyala province. | |
| Indriani et al. | Vaccination of quails with bivalent inactivated H5N1 AI vaccine (clades 2.1. 3 and 2.3. 2) at laboratory scale | |
| Chen et al. | Duck diseases and disease management | |
| Abd El-Ghany | Forms of avian reovirus in poultry production: An overview |